Occupational Situation and Return to Work of Urological Patients
Launched by JAGIELLONIAN UNIVERSITY · Jul 20, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how treatment for certain urological conditions—like bladder, prostate, or kidney cancer, and urinary stones—affects patients’ ability to work and their overall quality of life. Researchers at the University Hospital in Kraków, Poland, will ask all adult patients admitted for these conditions over six months about their job situation. For patients who are working and having major surgeries or procedures related to their illness, the study will also check in with them by phone three and six months after treatment to see how they’re doing and whether they’ve been able to return to work.
To take part, you need to be an adult patient admitted to the hospital’s urology department during the study period. If you are working and scheduled for major surgery or treatment for urinary stones, you may be asked to complete a questionnaire about your quality of life and participate in follow-up phone calls. Patients who are not working or retired will still be asked about their job status but won’t be followed up in the same way. The goal is to better understand how these treatments affect daily life and work, so hospitals can improve support and rehabilitation for patients after their care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients (≥18 years) admitted to the Department of Urology and Oncological Urology, University Hospital in Kraków, during the 6-month study period.
- 2. For the prospective follow-up cohort:
- • 1. Occupationally active (employed) at baseline.
- • 2. Undergoing major uro-oncological surgery (e.g., radical cystectomy, radical prostatectomy, nephrectomy) or a procedure for urinary tract stones (e.g., ureterorenoscopy, percutaneous nephrolithotripsy).
- • 3. Able and willing to provide written informed consent.
- Exclusion Criteria:
- • 1. Patients unwilling or unable to provide informed consent.
- • 2. Patients who are unemployed or retired at baseline (excluded from the prospective follow-up cohort but included in the baseline cross-sectional survey).
- • 3. Patients not undergoing major uro-oncological surgery or urinary tract stone procedures (for the prospective follow-up cohort).
About Jagiellonian University
Jagiellonian University, one of the oldest and most prestigious institutions of higher education in Poland, is a leading sponsor of clinical trials dedicated to advancing medical research and healthcare innovation. With a strong commitment to scientific excellence, the university leverages its extensive resources, multidisciplinary expertise, and collaborative network to conduct rigorous clinical studies that contribute to the development of new therapies and treatment strategies. Jagiellonian University emphasizes ethical research practices and strives to enhance patient outcomes through evidence-based findings, making significant contributions to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Krakow, Malopolska, Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported